121 related articles for article (PubMed ID: 37872130)
21. Psychometric properties of the EORTC QLQ-C30 in Uganda.
Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
[TBL] [Abstract][Full Text] [Related]
22. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
[TBL] [Abstract][Full Text] [Related]
23. Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer.
Kinoshita Y; Izukura R; Kishimoto J; Kanaoka M; Fujita H; Ando K; Nagai S; Akiyoshi S; Tagawa T; Kubo M; Inokuchi J; Ohuchida K; Oki E; Tanaka K; Eto M; Yoshizumi T; Nakamura M; Chishaki A
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4899-4914. PubMed ID: 36307557
[TBL] [Abstract][Full Text] [Related]
24. Health-related quality of life among breast cancer patients in India.
Gupta N; Pandey AK; Dimri K; Jyani G; Goyal A; Prinja S
Support Care Cancer; 2022 Dec; 30(12):9983-9990. PubMed ID: 36222977
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in breast cancer patients in Asia: A meta-analysis and systematic review.
Chen X; Wu C; Bai D; Gao J; Hou C; Chen T; Zhang L; Luo H
Front Oncol; 2022; 12():954179. PubMed ID: 36249065
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy.
Campone M; Beck JT; Gnant M; Neven P; Pritchard KI; Bachelot T; Provencher L; Rugo HS; Piccart M; Hortobagyi GN; Nunzi M; Heng DY; Baselga J; Komorowski A; Noguchi S; Horiguchi J; Bennett L; Ziemiecki R; Zhang J; Cahana A; Taran T; Sahmoud T; Burris HA
Curr Med Res Opin; 2013 Nov; 29(11):1463-73. PubMed ID: 23962028
[TBL] [Abstract][Full Text] [Related]
27. Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients.
Anota A; Bascoul-Mollevi C; Conroy T; Guillemin F; Velten M; Jolly D; Mercier M; Causeret S; Cuisenier J; Graesslin O; Hamidou Z; Bonnetain F
Health Qual Life Outcomes; 2014 Mar; 12():32. PubMed ID: 24606836
[TBL] [Abstract][Full Text] [Related]
28. Reliability and Validity of the Arabic Version of the EORTC QLQ-C30 and QLQ-BR23 Questionnaires.
Jassim G; AlAnsari A
Neuropsychiatr Dis Treat; 2020; 16():3045-3052. PubMed ID: 33335396
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
Schwartzberg L; McIntyre K; Wilks S; Puhalla S; O'Shaughnessy J; Berrak E; He Y; Vahdat L
BMC Cancer; 2019 Jun; 19(1):578. PubMed ID: 31195996
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
[TBL] [Abstract][Full Text] [Related]
32. Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in Japan.
Okamoto T; Shimozuma K; Katsumata N; Koike M; Hisashige A; Tanaka K; Ohsumi S; Saito M; Shikama N; Mitsumori M; Yamauchi C; Watanabe T;
Breast Cancer; 2003; 10(3):204-13. PubMed ID: 12955032
[TBL] [Abstract][Full Text] [Related]
33. Reliability and Validity of the EORTC QLQ-CIPN20 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale) among Thai Women with Breast Cancer Undergoing Taxane-Based Chemotherapy.
Rattanakrong N; Thipprasopchock S; Siriphorn A; Boonyong S
Asian Pac J Cancer Prev; 2022 May; 23(5):1547-1553. PubMed ID: 35633537
[TBL] [Abstract][Full Text] [Related]
34. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
35. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
[TBL] [Abstract][Full Text] [Related]
36. Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
Schmid P; Lipatov O; Im SA; Goncalves A; Muñoz-Couselo E; Lee KS; Tamura K; Testa L; Witzel I; Ohtani S; Turner N; Zambelli S; Harbeck N; Andre F; Dent R; Mejia JA; Zhou X; Haiderali A; Nguyen AM; Cortes J; Winer EP
Eur J Cancer; 2023 Dec; 195():113393. PubMed ID: 37976633
[TBL] [Abstract][Full Text] [Related]
37. Challenging the current norm: Does health related quality of life data from reference populations accurately reflect baseline values in breast cancer patients? An observational cohort study comparing EORTC QLQ-C30 scores between the general Swedish population and baseline scores in breast cancer patients.
Sjökvist O; Håkansson S; Pantiora E; Karakatsanis A
Eur J Surg Oncol; 2021 Dec; 47(12):2971-2977. PubMed ID: 34412955
[TBL] [Abstract][Full Text] [Related]
38. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
[TBL] [Abstract][Full Text] [Related]
39. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
[TBL] [Abstract][Full Text] [Related]
40. Quality of life in breast and colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires.
Mosconi P; Apolone G; Barni S; Secondino S; Sbanotto A; Filiberti A
Tumori; 2002; 88(2):110-6. PubMed ID: 12088249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
